July 9, 2019

FDA: Class I recall of Edwards Lifesciences’ IntraClude Intra-Aortic Occlusion Device

By: Judy Mathias

Editor’s Note

The Food and Drug Administration on July 1 identified the recall by Edwards Lifesciences (Irvine, California) of its IntraClude Intra-Aortic Occlusion Device as Class I, the most serious.

The recall was initiated because of a risk of balloon rupture during use in patients undergoing cardiopulmonary bypass.

The company has received 22 complaints associated with balloon rupture or puncture, and three deaths have been reported.


Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Upcoming Webinars
Live chat by BoldChat